98%
921
2 minutes
20
Background: Occult heart failure with preserved ejection fraction (HFpEF), characterized by elevated pulmonary arterial wedge pressure during exercise (PAWP), has gained attention in the context of pulmonary hypertension (PH). This study aimed to evaluate the prevalence of occult HFpEF and assess the diagnostic efficacy of passive leg raise (PLR) in patients with confirmed or suspected PH.
Methods: A total of 619 patients with normal resting PAWP underwent symptom-limited exercise testing using a supine cycle ergometer in conjunction with right heart catheterization (RHC) for PH diagnosis and treatment assessment. Occult HFpEF was defined as PAWP ≥ 25 mmHg. Receiver operating characteristic curves were constructed, and the area under the curve (AUC) was calculated to evaluate the diagnostic utility of PAWP for identifying occult HFpEF.
Results: Among the 619 patients (median age: 61 years, 78% female; median PAWP at rest: 8 mmHg), 80 (13%) demonstrated occult HFpEF. The prevalence was 7%, 21%, and 16% in patients aged < 60 years, 60-69 years, and ≥ 70 years, respectively. PAWP was significantly elevated in the occult HFpEF group compared to the non-HFpEF group across all age categories. The AUC values for detecting occult HFpEF using PAWP were 0.75 for patients < 60 years, 0.78 for those aged 60-69 years, and 0.79 for those ≥ 70 years, with respective cut-off values of 14, 13, and 13 mmHg.
Conclusions: Occult HFpEF is prevalent among patients with PH. PAWP serves as a valuable, non-invasive tool, necessitating age-specific thresholds to enhance diagnostic accuracy.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.healun.2025.04.020 | DOI Listing |
J Heart Lung Transplant
May 2025
Department of Cardiovascular Medicine, Kyorin University Hospital, Tokyo, Japan.
Background: Occult heart failure with preserved ejection fraction (HFpEF), characterized by elevated pulmonary arterial wedge pressure during exercise (PAWP), has gained attention in the context of pulmonary hypertension (PH). This study aimed to evaluate the prevalence of occult HFpEF and assess the diagnostic efficacy of passive leg raise (PLR) in patients with confirmed or suspected PH.
Methods: A total of 619 patients with normal resting PAWP underwent symptom-limited exercise testing using a supine cycle ergometer in conjunction with right heart catheterization (RHC) for PH diagnosis and treatment assessment.
Circ Heart Fail
August 2025
Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN (Y.N.V.R., R.P.F., B.A.B.).
Background: Patients with lung disease, sleep apnea, and chronic thromboemboli can develop pulmonary hypertension, currently classified as group 3 or 4. Many of these patients also have risk factors for heart failure with preserved ejection fraction (HFpEF), but the optimal approach to identify the disease overlap remains unclear.
Methods: Pretest probability for HFpEF was determined using the HFpEF-ABA (age, body mass index, atrial fibrillation) algorithm among adjudicated group 3 or 4 patients at risk for pulmonary hypertension in the PVDOMICS study (Redefining Pulmonary Hypertension Through Pulmonary Vascular Disease Phenomics).
Eur J Intern Med
January 2025
Department of Cardiology and Pneumology, University Medical Center Göttingen, Göttingen, Germany; DZHK (German Center for Cardiovascular Research), Partner Site Lower Saxony, Germany. Electronic address:
JACC Heart Fail
June 2024
Cleveland Clinic Health System, Cleveland, Ohio, USA.
Because of the bidirectional relationship between atrial fibrillation (AF) and heart failure with preserved ejection fraction (HFpEF), individuals with either condition require consideration of screening for the other. In this review, we summarize current evidence and rationale for screening for occult HFpEF in adults with clinical AF; and occult AF in patients with clinically recognized HFpEF. Assessment of pretest probability for occult HFpEF in symptomatic AF patients may help guide additional testing such as exercise right heart catheterization to diagnose HFpEF and guide HFpEF-specific therapies.
View Article and Find Full Text PDFAm J Cardiol
October 2023
Division of Cardiovascular Medicine, University of Toledo, Toledo, Ohio.
Atrial fibrillation (AF) and heart failure with preserved ejection fraction (HFpEF) are frequent co-morbid conditions. In patients with symptomatic AF and preserved left ventricular ejection fraction the clinical diagnosis of HFpEF may be difficult, as history, examination, and echocardiography are not sensitive or specific. This study sought to assess the prevalence of HFpEF in patients undergoing AF ablation utilizing resting and post-tachycardia pacing left atrial pressure (LAP) measurements.
View Article and Find Full Text PDF